Literature DB >> 20368174

Common defects of ABCG2, a high-capacity urate exporter, cause gout: a function-based genetic analysis in a Japanese population.

Hirotaka Matsuo1, Tappei Takada, Kimiyoshi Ichida, Takahiro Nakamura, Akiyoshi Nakayama, Yuki Ikebuchi, Kousei Ito, Yasuyoshi Kusanagi, Toshinori Chiba, Shin Tadokoro, Yuzo Takada, Yuji Oikawa, Hiroki Inoue, Koji Suzuki, Rieko Okada, Junichiro Nishiyama, Hideharu Domoto, Satoru Watanabe, Masanori Fujita, Yuji Morimoto, Mariko Naito, Kazuko Nishio, Asahi Hishida, Kenji Wakai, Yatami Asai, Kazuki Niwa, Keiko Kamakura, Shigeaki Nonoyama, Yutaka Sakurai, Tatsuo Hosoya, Yoshikatsu Kanai, Hiroshi Suzuki, Nobuyuki Hamajima, Nariyoshi Shinomiya.   

Abstract

Gout based on hyperuricemia is a common disease with a genetic predisposition, which causes acute arthritis. The ABCG2/BCRP gene, located in a gout-susceptibility locus on chromosome 4q, has been identified by recent genome-wide association studies of serum uric acid concentrations and gout. Urate transport assays demonstrated that ABCG2 is a high-capacity urate secretion transporter. Sequencing of the ABCG2 gene in 90 hyperuricemia patients revealed several nonfunctional ABCG2 mutations, including Q126X. Quantitative trait locus analysis of 739 individuals showed that a common dysfunctional variant of ABCG2, Q141K, increases serum uric acid. Q126X is assigned to the different disease haplotype from Q141K and increases gout risk, conferring an odds ratio of 5.97. Furthermore, 10% of gout patients (16 out of 159 cases) had genotype combinations resulting in more than 75% reduction of ABCG2 function (odds ratio, 25.8). Our findings indicate that nonfunctional variants of ABCG2 essentially block gut and renal urate excretion and cause gout.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20368174     DOI: 10.1126/scitranslmed.3000237

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN: 1946-6234            Impact factor:   17.956


  152 in total

1.  ABCG2 null alleles define the Jr(a-) blood group phenotype.

Authors:  Teresa Zelinski; Gail Coghlan; Xiao-Qing Liu; Marion E Reid
Journal:  Nat Genet       Date:  2012-01-15       Impact factor: 38.330

2.  Posttranslational negative regulation of glycosylated and non-glycosylated BCRP expression by Derlin-1.

Authors:  Takashi Sugiyama; Tsuyoshi Shuto; Shingo Suzuki; Takashi Sato; Tomoaki Koga; Mary Ann Suico; Hiroyuki Kusuhara; Yuichi Sugiyama; Douglas M Cyr; Hirofumi Kai
Journal:  Biochem Biophys Res Commun       Date:  2010-12-22       Impact factor: 3.575

3.  A common variant of MAF/c-MAF, transcriptional factor gene in the kidney, is associated with gout susceptibility.

Authors:  Toshihide Higashino; Hirotaka Matsuo; Yukinori Okada; Hiroshi Nakashima; Seiko Shimizu; Masayuki Sakiyama; Shin Tadokoro; Akiyoshi Nakayama; Makoto Kawaguchi; Mako Komatsu; Asahi Hishida; Masahiro Nakatochi; Hiroshi Ooyama; Junko Imaki; Nariyoshi Shinomiya
Journal:  Hum Cell       Date:  2017-10-28       Impact factor: 4.174

Review 4.  ABCG transporters and disease.

Authors:  Owen M Woodward; Anna Köttgen; Michael Köttgen
Journal:  FEBS J       Date:  2011-06-13       Impact factor: 5.542

5.  Sulfasalazine disposition in a subject with 376C>T (nonsense mutation) and 421C>A variants in the ABCG2 gene.

Authors:  Keisuke Gotanda; Tomoko Tokumoto; Takeshi Hirota; Masato Fukae; Ichiro Ieiri
Journal:  Br J Clin Pharmacol       Date:  2015-06-05       Impact factor: 4.335

6.  ABCG2 requires a single aromatic amino acid to "clamp" substrates and inhibitors into the binding pocket.

Authors:  Tomoka Gose; Talha Shafi; Yu Fukuda; Sourav Das; Yao Wang; Alice Allcock; Ailsa Gavan McHarg; John Lynch; Taosheng Chen; Ikumi Tamai; Anang Shelat; Robert C Ford; John D Schuetz
Journal:  FASEB J       Date:  2020-02-17       Impact factor: 5.191

7.  Uric acid transporter ABCG2 is increased in the intestine of the 5/6 nephrectomy rat model of chronic kidney disease.

Authors:  Hirofumi Yano; Yoshifuru Tamura; Kana Kobayashi; Masayuki Tanemoto; Shunya Uchida
Journal:  Clin Exp Nephrol       Date:  2013-04-13       Impact factor: 2.801

8.  Gout-causing Q141K mutation in ABCG2 leads to instability of the nucleotide-binding domain and can be corrected with small molecules.

Authors:  Owen M Woodward; Deepali N Tukaye; Jinming Cui; Patrick Greenwell; Leeza M Constantoulakis; Benjamin S Parker; Anjana Rao; Michael Köttgen; Peter C Maloney; William B Guggino
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-14       Impact factor: 11.205

Review 9.  PharmGKB summary: very important pharmacogene information for ABCG2.

Authors:  Alison E Fohner; Deanna J Brackman; Kathleen M Giacomini; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2017-11       Impact factor: 2.089

10.  What lies behind serum urate concentration? Insights from genetic and genomic studies.

Authors:  Kimiyoshi Ichida
Journal:  Genome Med       Date:  2009-12-29       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.